EP Patent

EP2332947B1 — Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use

Assigned to Lexicon Pharmaceuticals Inc · Expires 2017-11-01 · 9y expired

What this patent protects

Patent listed against Inpefa.

Drugs covered by this patent

Patent Metadata

Patent number
EP2332947B1
Jurisdiction
EP
Classification
—
Expires
2017-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Lexicon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.